Based on the PIONEER programme, oral semaglutide has been licensed for people with T2D and the 14 mg dose, leads to HbA1c improvement up to 1.4% and WL up to 4.4 kg [20]
10.1016/j.jhep.2018.06.008 39 Len-MimilaP.Villamil-RamrezH.LiX
JAMA , 332 (1), 8
Zeldich E, Chen CD, Colvin TA, Bove-Fenderson EA, Liang J, Tucker Zhou TB, Harris DA, Abraham CR (2014) The neuroprotective effect of Klotho is mediated via regulation of members of the redox system
Tirzepatide dry mouth is manageable with hydration
Hypothesized factors include baseline appetite, concurrent medications, compensatory increases in calorie intake, or the restoration of appetite once depression liftsany of which can offset bupropions appetite-suppressing effects and lead to weight normalization or gain